Skip to content
10-K

Annual Report

SKINOVATION PHARMACEUTICAL INCORPORATED

0001554795-23-000098

← back to feed
Filed
Mar 30, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Mar 28, 2023 708K sh
Operating Cash Flow FY 2022 · Dec 31, 2021 −$6.83K
Cash And Equivalents FY 2022 · Dec 31, 2021 $222
Current Liabilities FY 2022 · Dec 31, 2021 $377.81K
Total Liabilities FY 2022 · Dec 31, 2021 $377.81K
Current Assets FY 2022 · Dec 31, 2021 $222
Total Assets FY 2022 · Dec 31, 2021 $222
Eps Basic FY 2022 · Dec 31, 2021 −$0.05
Sga Expense FY 2022 · Dec 31, 2021 $13.83K
Net Income FY 2022 · Dec 31, 2021 −$32.45K
Operating Income FY 2022 · Dec 31, 2021 −$13.83K
Stockholders Equity FY 2022 · Dec 31, 2020 −$345.14K